FF
PMVP icon

FourThought Financial’s PMV Pharmaceuticals PMVP Stock Holding History

FourThought Financial’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+52
New +$751 ﹤0.01% 1442

Other funds holding PMVP

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

FourThought Financial's PMVP Position: Q3 2022 in Review

FourThought Financial opened a new position in PMV Pharmaceuticals (PMVP) in Q3 2022: 52 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1442 among its holdings.

120 funds tracked by Wall St. Rank hold PMVP as of Q3 2022.

  • FourThought Financial held 52 shares of PMV Pharmaceuticals worth $1K as of Q3 2022.
  • PMV Pharmaceuticals was a new FourThought Financial position in Q3 2022.
  • PMV Pharmaceuticals made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1442 holding.
  • 120 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.